Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014

News provided by

Research and Markets

19 Aug, 2014, 01:32 ET

DUBLIN, Aug. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report to their offering.

Continue Reading
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousand by the following Dosage Forms: Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms (Tablets and Capsules), and Liquid & Semi-solid Dosage Forms (Syrups, Suspensions, Gels, Creams & Ointments).

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 92 companies including many key and niche players such as:

  • AAIPharma Services Corporation
  • Aenova Group
  • Ajinomoto Althea, Inc.
  • Albany Molecular Research, Inc.
  • Dishman

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
2. MAJOR MARKET TRENDS & ISSUES
3. COMPETITIVE LANDSCAPE
4. SERVICE OVERVIEW
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT GLOBAL PLAYERS
7. GLOBAL MARKET PERSPECTIVE

III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 92 The United States (34)

  • Canada (3)
  • Japan (4)
  • Europe (33)
  • France (3)
  • Germany (8)
  • The United Kingdom (9)
  • Italy (3)
  • Rest of Europe (10)
  • Asia-Pacific (Excluding Japan) (18)

For more information visit http://www.researchandmarkets.com/research/3gl53c/pharmaceutical

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets

Also from this source

European Cybersecurity Landscape End-User Survey - Cybersecurity Budget Allocation and Risk Perceptions

European Cybersecurity Landscape End-User Survey - Cybersecurity Budget Allocation and Risk Perceptions

The "European Voice of the Enterprise Security Customer-Trends" report has been added to ResearchAndMarkets.com's offering. This report presents a...
China Membrane Bioreactor Market Report 2023: Competition, Forecast & Opportunities to 2028 - MBRs Drive the Shift Towards Sustainable Water Management to Address Water Scarcity

China Membrane Bioreactor Market Report 2023: Competition, Forecast & Opportunities to 2028 - MBRs Drive the Shift Towards Sustainable Water Management to Address Water Scarcity

The "China Membrane Bioreactor Market, Competition, Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering. The...
More Releases From This Source

Explore

Image1

Health Care & Hospitals

Image1

Medical Pharmaceuticals

Image1

Pharmaceuticals

Image1

Surveys, Polls and Research

News Releases in Similar Topics

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.